Galapagos NV
GLPG
#4563
Rank
C$2.91 B
Marketcap
C$43.64
Share price
-0.57%
Change (1 day)
15.49%
Change (1 year)

Galapagos NV (GLPG) - Net assets

Net assets on the balance sheet as of September 2025 : C$3.96 Billion

According to Galapagos NV's latest financial reports the company has C$3.96 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Galapagos NV - Net assets on balance sheet (from 2008 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$C$4.32 B5.54%
2023-12-31$C$4.09 B11.48%
2022-12-31$C$3.67 B-3.63%
2021-12-31$C$3.81 B-8.9%
2020-12-31$C$4.18 B-0.46%
2019-12-31$C$4.20 B122.35%
2018-12-31$C$1.89 B23.95%
2017-12-31$C$1.52 B42.35%
2016-12-31$C$1.07 B93.72%
2015-12-31$C$0.55 B90.29%
2014-12-31$C$0.29 B18.41%
2013-12-31$C$0.24 B57.7%
2012-12-31$C$0.15 B-0.37%
2011-12-31$C$0.15 B-20.81%
2010-12-31$C$0.19 B20.3%
2009-12-31$C$0.16 B14.51%
2008-12-31$C$0.14 B-0.23%
2007-12-31$C$0.14 B-14.64%
2006-12-31$C$0.16 B99.59%
2005-12-31$C$84.31 M399.19%
2004-12-31$C$16.89 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
AstraZeneca
AZN
C$63.50 B 1,500.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
C$109.52 B 2,660.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$119.21 B 2,905.07%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
-C$3.6 Billion-190.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
C$51.64 M-98.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$70.82 B 1,685.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$10.02 B 152.60%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
C$29.25 B 637.40%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
C$71.70 B 1,707.52%๐Ÿ‡บ๐Ÿ‡ธ USA